WST

SELL

West Pharmaceutical Services, I

Healthcare · Rank #135 · Analyzed Apr 20, 2026

$273.73

Current Price

$63.77

Intrinsic Value

-75.3%

Upside/Downside

4/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score4/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 75.3%

Fair Value Range

Low$35.25

Base (IV)$63.77

High$67.58

Entry Points

Conservative$35.25

Moderate$49.51

Aggressive$63.77

Quality & Moat Breakdown

Return on Equity16.9% → 1.0/1.0

Debt LevelD/E 10 → 1.0/1.0

Revenue QualityGrowth 4.0%, margin Δ+3.3% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins16.1% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.